vimarsana.com
Home
Live Updates
Hobbs Highlights Key Research in Hematologic Malignancies at
Hobbs Highlights Key Research in Hematologic Malignancies at
Hobbs Highlights Key Research in Hematologic Malignancies at the 2023 ASH Annual Meeting
Gabriela Hobbs, MD, discusses the significance of key research across myeloproliferative neoplasms from the 2023 ASH Annual Meeting.
Related Keywords
Gabriela Hobbs ,
Ruxolitinib Jakafi ,
News Network ,
News ,
Ruxolitinib ,
Myelofibrosis ,
Myeloproliferative Neoplasms ,
D ,
Splenomegaly ,